Pet Healthcare in Asia-Pacific

  • ID: 4515381
  • Report
  • Region: Asia Pacific
  • 36 pages
  • MarketLine
1 of 4

FEATURED COMPANIES

  • Bayer AG
  • DoggyMan H.A.Co., Ltd.
  • Eli Lilly and Company
  • Zoetis Inc.
  • MORE
Pet Healthcare in Asia-Pacific

Summary

Pet Healthcare in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the Asia-Pacific pet healthcare market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights
  • The pet healthcare market consists of retail sale of pet supplements, worming treatments, external parasite treatments, grooming products and other pet healthcare. The market is valued according to retail selling price (RSP) and includes any applicable taxes. All currency conversions used in the creation of this report have been calculated using constant annual average 2017 exchange rates.
  • The Asia-Pacific pet healthcare market had total revenues of $2,139.6m in 2017, representing a compound annual growth rate (CAGR) of 5.0% between 2013 and 2017.
  • Market consumption volume increased with a CAGR of 3.4% between 2013 and 2017, to reach a total of 235.7 million units in 2017.
  • The strong performance of the Indian, South Korean and Japanese pet healthcare markets supported overall Asia-Pacific pet healthcare market growth.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in Asia-Pacific
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in Asia-Pacific
  • Leading company profiles reveal details of key pet healthcare market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pet healthcare market with five year forecasts by both value and volume
Reasons to buy
  • What was the size of the Asia-Pacific pet healthcare market by value in 2017?
  • What will be the size of the Asia-Pacific pet healthcare market in 2022?
  • What factors are affecting the strength of competition in the Asia-Pacific pet healthcare market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Asia-Pacific's pet healthcare market?
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • DoggyMan H.A.Co., Ltd.
  • Eli Lilly and Company
  • Zoetis Inc.
  • MORE
Executive Summary
Market value
Market value forecast
Market volume
Market volume forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market volume
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Market volume forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
DoggyMan H.A.Co., Ltd.
Eli Lilly and Company
Zoetis Inc.
Methodology
Industry associations
Related Research
Appendix
About the Author

List of Tables
Table 1: Asia-Pacific pet healthcare market value: $ million, 2013–17
Table 2: Asia–Pacific pet healthcare market volume: million units, 2013–17
Table 3: Asia–Pacific pet healthcare market category segmentation: $ million, 2017
Table 4: Asia–Pacific pet healthcare market geography segmentation: $ million, 2017
Table 5: Asia-Pacific pet healthcare market share: % share, by value, 2017
Table 6: Asia-Pacific pet healthcare market distribution: % share, by value, 2017
Table 7: Asia-Pacific pet healthcare market value forecast: $ million, 2017–22
Table 8: Asia–Pacific pet healthcare market volume forecast: million units, 2017–22
Table 9: Bayer AG: key facts
Table 10: Bayer AG: key financials ($)
Table 11: Bayer AG: key financials (€)
Table 12: Bayer AG: key financial ratios
Table 13: DoggyMan H.A.Co., Ltd.: key facts
Table 14: Eli Lilly and Company: key facts
Table 15: Eli Lilly and Company: key financials ($)
Table 16: Eli Lilly and Company: key financial ratios
Table 17: Zoetis Inc.: key facts
Table 18: Zoetis Inc.: key financials ($)
Table 19: Zoetis Inc.: key financial ratios

List of Figures
Figure 1: Asia-Pacific pet healthcare market value: $ million, 2013–17
Figure 2: Asia–Pacific pet healthcare market volume: million units, 2013–17
Figure 3: Asia–Pacific pet healthcare market category segmentation: % share, by value, 2017
Figure 4: Asia–Pacific pet healthcare market geography segmentation: % share, by value, 2017
Figure 5: Asia-Pacific pet healthcare market share: % share, by value, 2017
Figure 6: Asia-Pacific pet healthcare market distribution: % share, by value, 2017
Figure 7: Asia-Pacific pet healthcare market value forecast: $ million, 2017–22
Figure 8: Asia–Pacific pet healthcare market volume forecast: million units, 2017–22
Figure 9: Forces driving competition in the pet healthcare market in Asia-Pacific, 2017
Figure 10: Drivers of buyer power in the pet healthcare market in Asia-Pacific, 2017
Figure 11: Drivers of supplier power in the pet healthcare market in Asia-Pacific, 2017
Figure 12: Factors influencing the likelihood of new entrants in the pet healthcare market in Asia-Pacific, 2017
Figure 13: Factors influencing the threat of substitutes in the pet healthcare market in Asia-Pacific, 2017
Figure 14: Drivers of degree of rivalry in the pet healthcare market in Asia-Pacific, 2017
Figure 15: Bayer AG: revenues & profitability
Figure 16: Bayer AG: assets & liabilities
Figure 17: Eli Lilly and Company: revenues & profitability
Figure 18: Eli Lilly and Company: assets & liabilities
Figure 19: Zoetis Inc.: revenues & profitability
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer AG
  • DoggyMan H.A.Co., Ltd.
  • Eli Lilly and Company
  • Zoetis Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll